 | • レポートコード：MRC2312MG15331 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の植込み型仙骨神経刺激装置市場規模と予測を収録しています。・世界の植込み型仙骨神経刺激装置市場：売上、2018年-2023年、2024年-2029年 ・世界の植込み型仙骨神経刺激装置市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の植込み型仙骨神経刺激装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「仙骨神経刺激」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 植込み型仙骨神経刺激装置のグローバル主要企業は、Medtronic、 Abbott、 Boston Scientific、 Nuvectra、 Axonics、 Laborie、 Neuropace、 Neuspera、 PINS Medical、 General Stim、 Nurotronなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、植込み型仙骨神経刺激装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の植込み型仙骨神経刺激装置市場：タイプ別、2018年-2023年、2024年-2029年 世界の植込み型仙骨神経刺激装置市場：タイプ別市場シェア、2022年 ・仙骨神経刺激、ニューロモジュレーション 世界の植込み型仙骨神経刺激装置市場：用途別、2018年-2023年、2024年-2029年 世界の植込み型仙骨神経刺激装置市場：用途別市場シェア、2022年 ・慢性便失禁、切迫性尿失禁、頻尿、尿意切迫、その他 世界の植込み型仙骨神経刺激装置市場：地域・国別、2018年-2023年、2024年-2029年 世界の植込み型仙骨神経刺激装置市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における植込み型仙骨神経刺激装置のグローバル売上、2018年-2023年 ・主要企業における植込み型仙骨神経刺激装置のグローバル売上シェア、2022年 ・主要企業における植込み型仙骨神経刺激装置のグローバル販売量、2018年-2023年 ・主要企業における植込み型仙骨神経刺激装置のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Medtronic、 Abbott、 Boston Scientific、 Nuvectra、 Axonics、 Laborie、 Neuropace、 Neuspera、 PINS Medical、 General Stim、 Nurotron ************************************************************* ・調査・分析レポートの概要 植込み型仙骨神経刺激装置市場の定義 市場セグメント 世界の植込み型仙骨神経刺激装置市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の植込み型仙骨神経刺激装置市場規模 世界の植込み型仙骨神経刺激装置市場規模：2022年 VS 2029年 世界の植込み型仙骨神経刺激装置市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの植込み型仙骨神経刺激装置の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の植込み型仙骨神経刺激装置製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：仙骨神経刺激、ニューロモジュレーション 植込み型仙骨神経刺激装置のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：慢性便失禁、切迫性尿失禁、頻尿、尿意切迫、その他 植込み型仙骨神経刺激装置の用途別グローバル売上・予測 ・地域別市場分析 地域別植込み型仙骨神経刺激装置市場規模 2022年と2029年 地域別植込み型仙骨神経刺激装置売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Medtronic、 Abbott、 Boston Scientific、 Nuvectra、 Axonics、 Laborie、 Neuropace、 Neuspera、 PINS Medical、 General Stim、 Nurotron ... |
This research report provides a comprehensive analysis of the Implantable Sacral Neurostimulation System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Implantable Sacral Neurostimulation System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Implantable Sacral Neurostimulation System, challenges faced by the industry, and potential opportunities for market players.
The global Implantable Sacral Neurostimulation System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Implantable Sacral Neurostimulation System market presents opportunities for various stakeholders, including Chronic Fecal Incontinence, Urge Incontinence. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Implantable Sacral Neurostimulation System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Implantable Sacral Neurostimulation System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Implantable Sacral Neurostimulation System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Implantable Sacral Neurostimulation System market.
Market Overview: The report provides a comprehensive overview of the Implantable Sacral Neurostimulation System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Sacral Nerve Stimulation, Neuromodulation), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Implantable Sacral Neurostimulation System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Implantable Sacral Neurostimulation System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Implantable Sacral Neurostimulation System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Implantable Sacral Neurostimulation System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Implantable Sacral Neurostimulation System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Implantable Sacral Neurostimulation System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Implantable Sacral Neurostimulation System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Implantable Sacral Neurostimulation System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Implantable Sacral Neurostimulation System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Sacral Nerve Stimulation
Neuromodulation
Market segment by Application
Chronic Fecal Incontinence
Urge Incontinence
Frequent Urination
Urgency Urination
Others
Global Implantable Sacral Neurostimulation System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Medtronic
Abbott
Boston Scientific
Nuvectra
Axonics
Laborie
Neuropace
Neuspera
PINS Medical
General Stim
Nurotron
Outline of Major Chapters:
Chapter 1: Introduces the definition of Implantable Sacral Neurostimulation System, market overview.
Chapter 2: Global Implantable Sacral Neurostimulation System market size in revenue and volume.
Chapter 3: Detailed analysis of Implantable Sacral Neurostimulation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Implantable Sacral Neurostimulation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Implantable Sacral Neurostimulation System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Implantable Sacral Neurostimulation System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Implantable Sacral Neurostimulation System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Implantable Sacral Neurostimulation System Overall Market Size
2.1 Global Implantable Sacral Neurostimulation System Market Size: 2022 VS 2029
2.2 Global Implantable Sacral Neurostimulation System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Implantable Sacral Neurostimulation System Sales: 2018-2029
3 Company Landscape
3.1 Top Implantable Sacral Neurostimulation System Players in Global Market
3.2 Top Global Implantable Sacral Neurostimulation System Companies Ranked by Revenue
3.3 Global Implantable Sacral Neurostimulation System Revenue by Companies
3.4 Global Implantable Sacral Neurostimulation System Sales by Companies
3.5 Global Implantable Sacral Neurostimulation System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Implantable Sacral Neurostimulation System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Implantable Sacral Neurostimulation System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Implantable Sacral Neurostimulation System Players in Global Market
3.8.1 List of Global Tier 1 Implantable Sacral Neurostimulation System Companies
3.8.2 List of Global Tier 2 and Tier 3 Implantable Sacral Neurostimulation System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Implantable Sacral Neurostimulation System Market Size Markets, 2022 & 2029
4.1.2 Sacral Nerve Stimulation
4.1.3 Neuromodulation
4.2 By Type – Global Implantable Sacral Neurostimulation System Revenue & Forecasts
4.2.1 By Type – Global Implantable Sacral Neurostimulation System Revenue, 2018-2023
4.2.2 By Type – Global Implantable Sacral Neurostimulation System Revenue, 2024-2029
4.2.3 By Type – Global Implantable Sacral Neurostimulation System Revenue Market Share, 2018-2029
4.3 By Type – Global Implantable Sacral Neurostimulation System Sales & Forecasts
4.3.1 By Type – Global Implantable Sacral Neurostimulation System Sales, 2018-2023
4.3.2 By Type – Global Implantable Sacral Neurostimulation System Sales, 2024-2029
4.3.3 By Type – Global Implantable Sacral Neurostimulation System Sales Market Share, 2018-2029
4.4 By Type – Global Implantable Sacral Neurostimulation System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Implantable Sacral Neurostimulation System Market Size, 2022 & 2029
5.1.2 Chronic Fecal Incontinence
5.1.3 Urge Incontinence
5.1.4 Frequent Urination
5.1.5 Urgency Urination
5.1.6 Others
5.2 By Application – Global Implantable Sacral Neurostimulation System Revenue & Forecasts
5.2.1 By Application – Global Implantable Sacral Neurostimulation System Revenue, 2018-2023
5.2.2 By Application – Global Implantable Sacral Neurostimulation System Revenue, 2024-2029
5.2.3 By Application – Global Implantable Sacral Neurostimulation System Revenue Market Share, 2018-2029
5.3 By Application – Global Implantable Sacral Neurostimulation System Sales & Forecasts
5.3.1 By Application – Global Implantable Sacral Neurostimulation System Sales, 2018-2023
5.3.2 By Application – Global Implantable Sacral Neurostimulation System Sales, 2024-2029
5.3.3 By Application – Global Implantable Sacral Neurostimulation System Sales Market Share, 2018-2029
5.4 By Application – Global Implantable Sacral Neurostimulation System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Implantable Sacral Neurostimulation System Market Size, 2022 & 2029
6.2 By Region – Global Implantable Sacral Neurostimulation System Revenue & Forecasts
6.2.1 By Region – Global Implantable Sacral Neurostimulation System Revenue, 2018-2023
6.2.2 By Region – Global Implantable Sacral Neurostimulation System Revenue, 2024-2029
6.2.3 By Region – Global Implantable Sacral Neurostimulation System Revenue Market Share, 2018-2029
6.3 By Region – Global Implantable Sacral Neurostimulation System Sales & Forecasts
6.3.1 By Region – Global Implantable Sacral Neurostimulation System Sales, 2018-2023
6.3.2 By Region – Global Implantable Sacral Neurostimulation System Sales, 2024-2029
6.3.3 By Region – Global Implantable Sacral Neurostimulation System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Implantable Sacral Neurostimulation System Revenue, 2018-2029
6.4.2 By Country – North America Implantable Sacral Neurostimulation System Sales, 2018-2029
6.4.3 US Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.4.4 Canada Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.4.5 Mexico Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Implantable Sacral Neurostimulation System Revenue, 2018-2029
6.5.2 By Country – Europe Implantable Sacral Neurostimulation System Sales, 2018-2029
6.5.3 Germany Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.5.4 France Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.5.5 U.K. Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.5.6 Italy Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.5.7 Russia Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.5.8 Nordic Countries Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.5.9 Benelux Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Implantable Sacral Neurostimulation System Revenue, 2018-2029
6.6.2 By Region – Asia Implantable Sacral Neurostimulation System Sales, 2018-2029
6.6.3 China Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.6.4 Japan Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.6.5 South Korea Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.6.6 Southeast Asia Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.6.7 India Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Implantable Sacral Neurostimulation System Revenue, 2018-2029
6.7.2 By Country – South America Implantable Sacral Neurostimulation System Sales, 2018-2029
6.7.3 Brazil Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.7.4 Argentina Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Implantable Sacral Neurostimulation System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Implantable Sacral Neurostimulation System Sales, 2018-2029
6.8.3 Turkey Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.8.4 Israel Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.8.5 Saudi Arabia Implantable Sacral Neurostimulation System Market Size, 2018-2029
6.8.6 UAE Implantable Sacral Neurostimulation System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Implantable Sacral Neurostimulation System Major Product Offerings
7.1.4 Medtronic Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Implantable Sacral Neurostimulation System Major Product Offerings
7.2.4 Abbott Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Boston Scientific
7.3.1 Boston Scientific Company Summary
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Implantable Sacral Neurostimulation System Major Product Offerings
7.3.4 Boston Scientific Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.3.5 Boston Scientific Key News & Latest Developments
7.4 Nuvectra
7.4.1 Nuvectra Company Summary
7.4.2 Nuvectra Business Overview
7.4.3 Nuvectra Implantable Sacral Neurostimulation System Major Product Offerings
7.4.4 Nuvectra Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.4.5 Nuvectra Key News & Latest Developments
7.5 Axonics
7.5.1 Axonics Company Summary
7.5.2 Axonics Business Overview
7.5.3 Axonics Implantable Sacral Neurostimulation System Major Product Offerings
7.5.4 Axonics Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.5.5 Axonics Key News & Latest Developments
7.6 Laborie
7.6.1 Laborie Company Summary
7.6.2 Laborie Business Overview
7.6.3 Laborie Implantable Sacral Neurostimulation System Major Product Offerings
7.6.4 Laborie Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.6.5 Laborie Key News & Latest Developments
7.7 Neuropace
7.7.1 Neuropace Company Summary
7.7.2 Neuropace Business Overview
7.7.3 Neuropace Implantable Sacral Neurostimulation System Major Product Offerings
7.7.4 Neuropace Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.7.5 Neuropace Key News & Latest Developments
7.8 Neuspera
7.8.1 Neuspera Company Summary
7.8.2 Neuspera Business Overview
7.8.3 Neuspera Implantable Sacral Neurostimulation System Major Product Offerings
7.8.4 Neuspera Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.8.5 Neuspera Key News & Latest Developments
7.9 PINS Medical
7.9.1 PINS Medical Company Summary
7.9.2 PINS Medical Business Overview
7.9.3 PINS Medical Implantable Sacral Neurostimulation System Major Product Offerings
7.9.4 PINS Medical Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.9.5 PINS Medical Key News & Latest Developments
7.10 General Stim
7.10.1 General Stim Company Summary
7.10.2 General Stim Business Overview
7.10.3 General Stim Implantable Sacral Neurostimulation System Major Product Offerings
7.10.4 General Stim Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.10.5 General Stim Key News & Latest Developments
7.11 Nurotron
7.11.1 Nurotron Company Summary
7.11.2 Nurotron Business Overview
7.11.3 Nurotron Implantable Sacral Neurostimulation System Major Product Offerings
7.11.4 Nurotron Implantable Sacral Neurostimulation System Sales and Revenue in Global (2018-2023)
7.11.5 Nurotron Key News & Latest Developments
8 Global Implantable Sacral Neurostimulation System Production Capacity, Analysis
8.1 Global Implantable Sacral Neurostimulation System Production Capacity, 2018-2029
8.2 Implantable Sacral Neurostimulation System Production Capacity of Key Manufacturers in Global Market
8.3 Global Implantable Sacral Neurostimulation System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Implantable Sacral Neurostimulation System Supply Chain Analysis
10.1 Implantable Sacral Neurostimulation System Industry Value Chain
10.2 Implantable Sacral Neurostimulation System Upstream Market
10.3 Implantable Sacral Neurostimulation System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Implantable Sacral Neurostimulation System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer